Stock Analiz

GILD vs RVMD stock comparison

Gilead Sciences vs. Revolution Medicines · data as of November 13, 2026

Gilead Sciences (GILD) has a market value of about $208.5B, Revolution Medicines (RVMD) about $37.3B. Over their latest twelve months Gilead Sciences had revenue of $31.0B and Revolution Medicines $198M.

On our five checks Gilead Sciences scores higher: 2.8 out of 5 (average) against 0.6 (weak).

By area, the stronger company is Gilead Sciences on value; Gilead Sciences on future growth; Gilead Sciences on track record; Gilead Sciences on financial health; Gilead Sciences on shareholder returns.

Gilead Sciences leads on 13 of the compared lines and Revolution Medicines on 2.

Side by side

GILDRVMD
Size and price
Market cap$208.5B$37.3B
Share price$168.08$172.29
Score
Overall score (of 5)2.80.6
Value10
Future growth21
Track record40
Financial health32
Shareholder returns40
Valuation
P/E (TTM)——
Forward P/E20.3—
Price / free cash flow15.1—
Price / sales6.7188.6
EV / EBITDA559.5—
PEG——
DCF value vs. price−35%—
Business
Revenue$31.0B$198M
Net income-$3.9B-$1.9B
Free cash flow$13.8B-$1.4B
Net margin-12.5%-946.8%
Gross margin (5-yr avg.)77.6%—
ROIC (5-yr avg.)12.2%-36.5%
Growth
Revenue growth (1 yr)2.4%—
Revenue growth (5 yrs, per year)3.6%-100.0%
EPS growth (5 yrs, per year)132.4%—
Balance sheet and payouts
Net cash (cash minus debt)-$19.8B—
Dividend yield1.95%None
Shareholder yield2.9%0.0%
Analysts
Upside to average target+4%+59%
Consensus ratingBuyStrong buy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: GILD TTM to September 30, 2026, RVMD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Gilead Sciences or Revolution Medicines?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Gilead Sciences scores 2.8 out of 5 and Revolution Medicines 0.6; the table shows where each one is stronger.

Which grows faster, Gilead Sciences or Revolution Medicines?

Over five years Gilead Sciences grew revenue about 3.6% a year and Revolution Medicines about -100.0% a year.

Which pays a higher dividend?

Gilead Sciences yields 1.95% and Revolution Medicines nothing (no dividend).

Full Gilead Sciences analysis → Full Revolution Medicines analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.